Artelo Biosciences, Inc. (ARTL)
4.34
-0.51
(-10.52%)
USD |
NASDAQ |
Mar 26, 12:38
Artelo Biosciences Cash from Investing (Quarterly) : 0.1976M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.001M |
| Ovid Therapeutics, Inc. | -72.06M |
| Gossamer Bio, Inc. | 73.16M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.919M |
| Cash from Financing (Quarterly) | 1.580M |
| Free Cash Flow | -8.787M |
| Free Cash Flow Per Share (Quarterly) | -3.950 |
| Free Cash Flow to Equity (Quarterly) | -2.382M |
| Free Cash Flow to Firm (Quarterly) | -2.564M |
| Free Cash Flow Yield | -183.7% |